We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




MicroRNA Ratios Differentiate Melanomas from Nevi

By MedImaging International staff writers
Posted on 15 Oct 2019
A new study shows how an optical discrimination platform can detect malignant characteristics in a melanocytic tumor using specific microRNA (miRNA) patterns.

Developed at the University of California, San Francisco (UCSF; USA), the University of Utah (Salt Lake City, USA), and other institutions, the new technique applies a machine learning-based pipeline to a dataset consisting of genetic features, clinical features, and next-generation microRNA sequencing to tissues samples, in order to distinguish melanomas and their adjacent benign precursor nevi. The ML technique can detect eight specific expression ratios of miRNA patterns in the micro-dissected sections.

For the study, the researchers examined 82 biopsy specimens of moles and malignant melanomas, 41 of each type, taken from the medical records of the UCSF dermatopathology section. They then compared the new optical method of detecting malignant melanoma cells with the actual recorded outcomes. The results revealed a sensitivity of 81% and specificity of 88%, which was uninfluenced by either the age of the patient or by the presence of a large amount of benign cells in the same tumor. The study was published on June 20, 2019, in the Journal of Investigative Dermatology.

“We found that by developing a classifier based on a ratio of diagnostically important miRNA we could provide a more robust biomarker that was less susceptible to changes in tumor cell content and platform,” said lead author Rodrigo Torres, PhD, of UCSF. “The advantages of using miRNAs to distinguish benign and malignant melanocytic tumors include the fact that that they are easy to obtain from body fluids, are stable, inexpensive to measure and do not require very invasive techniques or a large amount of tissue.”

A miRNA is a short stretch of non-coding RNA that act to stop the production of protein by the RNA as and when indicated, typically by binding to a part of the RNA which is not involved in protein encoding. The miRNA expression profile variations between tissues, the relationships between them, and genetic and clinical features can help to identify the tissue a tumor originates from.

Related Links:
University of California, San Francisco
University of Utah


Portable X-ray Unit
AJEX140H
Ultra-Flat DR Detector
meX+1717SCC
New
Specimen Radiography System
Trident HD
New
Prostate Cancer MRI Analysis Tool
DynaCAD Urology
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

MRI

view channel
Image: The AI tool can help interpret and assess how well treatments are working for MS patients (Photo courtesy of Shutterstock)

AI Tool Tracks Effectiveness of Multiple Sclerosis Treatments Using Brain MRI Scans

Multiple sclerosis (MS) is a condition in which the immune system attacks the brain and spinal cord, leading to impairments in movement, sensation, and cognition. Magnetic Resonance Imaging (MRI) markers... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.